Ledger.Open graph →

SEC Form D · filed November 10, 2021

Arbor Biotechnologies, Inc

Offering

$215.0M

Sold

$215.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

CAMBRIDGE, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Keith Crandell · Chicago, ILDirector Kelly Morgan · CAMBRIDGE, MAExec David Walt · Cambridge, MADirector David Cheng · Santa Monica, CAExec Paul Meister · Seattle, WADirector Rami Harawi · CAMBRIDGE, MADirector John Murphy · Napa, CAExec Mark Angelino · Herndon, VADirector Pam Stetkiewicz · CAMBRIDGE, MAExec Devyn Smith · CAMBRIDGE, MAExec · Director Chen Yu · Palo Alto, CADirector David Cheng · Torrance, CAExec Paul Meister · High Point, NCDirector Rami Harawi · CAMBRIDGE, MADirector Keith Crandell · Chicago, ILDirector Kelly Morgan · CAMBRIDGE, MAExec John Murphy · Scottsdale, AZExec Mark Angelino · Cambridge, MADirector Pam Stetkiewicz · CAMBRIDGE, MAExec Devyn Smith · CAMBRIDGE, MAExec · Director Chen Yu · Palo Alto, CADirector David Walt · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗